Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |